Literature DB >> 19269977

Regulated proteolysis of nonmuscle myosin IIA stimulates osteoclast fusion.

Brooke K McMichael1, Robert B Wysolmerski, Beth S Lee.   

Abstract

The nonmuscle myosin IIA heavy chain (Myh9) is strongly associated with adhesion structures of osteoclasts. In this study, we demonstrate that during osteoclastogenesis, myosin IIA heavy chain levels are temporarily suppressed, an event that stimulates the onset of cell fusion. This suppression is not mediated by changes in mRNA or translational levels but instead is due to a temporary increase in the rate of myosin IIA degradation. Intracellular activity of cathepsin B is significantly enhanced at the onset of osteoclast precursor fusion, and specific inhibition of its activity prevents myosin IIA degradation. Further, treatment of normal cells with cathepsin B inhibitors during the differentiation process reduces cell fusion and bone resorption capacity, whereas overexpression of cathepsin B enhances fusion. Ongoing suppression of the myosin IIA heavy chain via RNA interference results in formation of large osteoclasts with significantly increased numbers of nuclei, whereas overexpression of myosin IIA results in less osteoclast fusion. Increased multinucleation caused by myosin IIA suppression does not require RANKL. Further, knockdown of myosin IIA enhances cell spreading and lessens motility. These data taken together strongly suggest that base-line expression of nonmuscle myosin IIA inhibits osteoclast precursor fusion and that a temporary, cathepsin B-mediated decrease in myosin IIA levels triggers precursor fusion during osteoclastogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19269977      PMCID: PMC2673295          DOI: 10.1074/jbc.M808621200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein.

Authors:  Olivier Destaing; Frédéric Saltel; Jean-Christophe Géminard; Pierre Jurdic; Frédéric Bard
Journal:  Mol Biol Cell       Date:  2003-02       Impact factor: 4.138

2.  Conditional expression of a truncated fragment of nonmuscle myosin II-A alters cell shape but not cytokinesis in HeLa cells.

Authors:  Q Wei; R S Adelstein
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

3.  Nonmuscle myosin IIA-dependent force inhibits cell spreading and drives F-actin flow.

Authors:  Yunfei Cai; Nicolas Biais; Gregory Giannone; Monica Tanase; Guoying Jiang; Jake M Hofman; Chris H Wiggins; Pascal Silberzan; Axel Buguin; Benoit Ladoux; Michael P Sheetz
Journal:  Biophys J       Date:  2006-08-18       Impact factor: 4.033

Review 4.  Podosome and sealing zone: specificity of the osteoclast model.

Authors:  Pierre Jurdic; Frédéric Saltel; Anne Chabadel; Olivier Destaing
Journal:  Eur J Cell Biol       Date:  2005-10-24       Impact factor: 4.492

5.  Myosin IIA regulates cell motility and actomyosin-microtubule crosstalk.

Authors:  Sharona Even-Ram; Andrew D Doyle; Mary Anne Conti; Kazue Matsumoto; Robert S Adelstein; Kenneth M Yamada
Journal:  Nat Cell Biol       Date:  2007-02-18       Impact factor: 28.824

6.  Selective inhibition of cathepsin B with cell-permeable CA074Me negatively affects L6 rat myoblast differentiation.

Authors:  Derek T Jane; Leslie C Morvay; Francis Allen; Bonnie F Sloane; Michael J Dufresne
Journal:  Biochem Cell Biol       Date:  2002       Impact factor: 3.626

7.  Cathepsin B is involved in the trafficking of TNF-alpha-containing vesicles to the plasma membrane in macrophages.

Authors:  Soon-Duck Ha; Andrew Martins; Khashayarsha Khazaie; Jiahuai Han; Bosco M C Chan; Sung Ouk Kim
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

8.  Cathepsin B-like proteolysis and MARCKS degradation in sub-lethal NMDA-induced collapse of dendritic spines.

Authors:  S Graber; S Maiti; Shelley Halpain
Journal:  Neuropharmacology       Date:  2004-10       Impact factor: 5.250

9.  Human nonmuscle myosin heavy chain mRNA: generation of diversity through alternative polyadenylylation.

Authors:  C G Saez; J C Myers; T B Shows; L A Leinwand
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

10.  CD44 occupancy prevents macrophage multinucleation.

Authors:  H Sterling; C Saginario; A Vignery
Journal:  J Cell Biol       Date:  1998-11-02       Impact factor: 10.539

View more
  20 in total

1.  An essential role for the association of CD47 to SHPS-1 in skeletal remodeling.

Authors:  Laura A Maile; Victoria E DeMambro; Christine Wai; Sutada Lotinun; Ariel W Aday; Byron E Capps; Wesley G Beamer; Clifford J Rosen; David R Clemmons
Journal:  J Bone Miner Res       Date:  2011-09       Impact factor: 6.741

2.  Galectin-3 Cleavage Alters Bone Remodeling: Different Outcomes in Breast and Prostate Cancer Skeletal Metastasis.

Authors:  Kosei Nakajima; Dhong Hyo Kho; Takashi Yanagawa; Yosuke Harazono; Victor Hogan; Wei Chen; Rouba Ali-Fehmi; Rohit Mehra; Avraham Raz
Journal:  Cancer Res       Date:  2016-02-02       Impact factor: 12.701

3.  Phosphoglycerol dihydroceramide, a distinctive ceramide produced by Porphyromonas gingivalis, promotes RANKL-induced osteoclastogenesis by acting on non-muscle myosin II-A (Myh9), an osteoclast cell fusion regulatory factor.

Authors:  Hiroyuki Kanzaki; Alexandru Movila; Rayyan Kayal; Marcelo H Napimoga; Kenji Egashira; Floyd Dewhirst; Hajime Sasaki; Mohammed Howait; Ayman Al-Dharrab; Abdulghani Mira; Xiaozhe Han; Martin A Taubman; Frank C Nichols; Toshihisa Kawai
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-01-31       Impact factor: 4.698

4.  Paxillin contracts the osteoclast cytoskeleton.

Authors:  Wei Zou; Carl J Deselm; Thomas J Broekelmann; Robert P Mecham; Scott Vande Pol; Kyunghee Choi; Steven L Teitelbaum
Journal:  J Bone Miner Res       Date:  2012-12       Impact factor: 6.741

5.  c-Src-mediated phosphorylation of thyroid hormone receptor-interacting protein 6 (TRIP6) promotes osteoclast sealing zone formation.

Authors:  Brooke K McMichael; Stephanie M Meyer; Beth S Lee
Journal:  J Biol Chem       Date:  2010-06-14       Impact factor: 5.157

6.  Quantitative proteomic analysis of dexamethasone-induced effects on osteoblast differentiation, proliferation, and apoptosis in MC3T3-E1 cells using SILAC.

Authors:  D Hong; H-X Chen; H-Q Yu; C Wang; H-T Deng; Q-Q Lian; R S Ge
Journal:  Osteoporos Int       Date:  2011-07       Impact factor: 4.507

7.  Myosin X regulates sealing zone patterning in osteoclasts through linkage of podosomes and microtubules.

Authors:  Brooke K McMichael; Richard E Cheney; Beth S Lee
Journal:  J Biol Chem       Date:  2010-01-17       Impact factor: 5.157

8.  Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone.

Authors:  L Endo-Munoz; A Cumming; S Sommerville; I Dickinson; N A Saunders
Journal:  Br J Cancer       Date:  2010-06-15       Impact factor: 7.640

Review 9.  Conventional myosins - unconventional functions.

Authors:  Peter D Chantler; Steven R Wylie; Caroline P Wheeler-Jones; Imelda M McGonnell
Journal:  Biophys Rev       Date:  2010-03-09

Review 10.  Genetic basis of cell-cell fusion mechanisms.

Authors:  Pablo S Aguilar; Mary K Baylies; Andre Fleissner; Laura Helming; Naokazu Inoue; Benjamin Podbilewicz; Hongmei Wang; Melissa Wong
Journal:  Trends Genet       Date:  2013-02-27       Impact factor: 11.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.